SCP-3876
Safe
~
medium confidence
SCP-3876
Expected annual
$46K
One-time setup
$67K
Annual recurring
$41K
Personnel
0.17
Initial one-time setup is modest (custom sealed display, monitoring hardware, and basic lab/storage) while recurring annual costs are dominated by partial senior researcher allocation and ongoing monitoring/supplies. Major cost drivers are an optional active research program and low-probability biosecurity responses.
One-Time Capital Costs
Total: $67K
Annual Recurring Costs
Total: $41K/yr
Cost Scenarios
📊
Baseline
(baseline)
$41K/yr
Normal year with routine monitoring, occasional manifestations handled with SOPs, no major incidents or expanded research.
routine monitoring
infrequent, contained manifestations
no emergency response or research scale-up
🚨
Minor Incident
$46K/yr
Localized manifestation event requiring extra security, cleanup, and a small battery of tests beyond routine screening.
large temporary manifestation (mess/obstruction)
extra security overtime
additional disposals and testing
🚨
Major Biosecurity Response
$111K/yr
Discovery of invasive species/pathogen in manifested material triggering broad quarantine, extensive testing, and decontamination.
pathogenic/invasive material detected
facility quarantine and HVAC decontamination
extensive testing and emergency cleanup
🚨
Research Breakthrough Requiring Scale Up
$191K/yr
Foundation initiates a dedicated active research program into manifestation mechanisms, sequencing, and controlled trials.
decision to fund active research
dedicated sequencing and experiments
additional staff hires and consumables
Personnel
0.17 total
| Role | Count | Notes |
|---|---|---|
| Research Scientist (Level-3 Researcher) | 0.17 | Fractional FTE allocation (approx. 0.15–0.17) covered by staff_wages estimate for on-call oversight, response, and specimen handling; other site staff (security/admin) are covered by site budgets and incremental lines above. |
Confidence Notes
Containment and recurring needs are well-documented in analyst notes and the article, yielding a moderately confident estimate; ranges in quoted item costs and optional/low-probability scenarios (research scale-up, biosecurity emergency) introduce uncertainty.